GeneDx Holdings Corp. (WGS) is a Healthcare · Diagnostics & Research company listed on NASDAQ. Price $101.10 (-3.67%), Market cap $1.41B, 52-week low–high $34.51 ~ $167.51.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
Financial statements, price targets, institutional (13F) holdings and related news for GeneDx Holdings Corp. are updated in real time on BlackAll Trade.
GeneDx Holdings Corp. trades at $101.10 (-3.67%). Real-time quotes and charts are available on BlackAll Trade.
GeneDx Holdings Corp. has a market cap of about $1.41B.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as